We are live on
!
Find out more
DAM
DLD Asset Management Portfolio holdings
AUM
$1.51B
Turnover
51.11%
1-Year Est. Return
5.32%
This Fund
S&P 500
This Quarter
Est. Return
+2.58%
1 Year Est. Return
+5.32%
3 Year Est. Return
+10.27%
5 Year Est. Return
+32.59%
10 Year Est. Return
–
AUM
$1.11B
AUM Growth
-$268M
(-19%)
Cap. Flow
-$325M
Cap. Flow
% of AUM
-29.32%
Top 10 Holdings %
Top 10 Hldgs %
47.88%
Holding
149
New
61
Increased
17
Reduced
6
Closed
45
Avg Time Held Equity + Options
0.2
years
Top 10 Avg Time Held Equity + Options
0.4
years
Top 20 Avg Time Held Equity + Options
0.3
years
Avg Time Held Equity only
0.2
years
Top 10 Avg Time Held Equity only
0.5
years
Top 20 Avg Time Held Equity only
0.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$19.7M |
| 2 |
LCI
Lannett Company, Inc.
LCI
|
+$17.8M |
| 3 |
PF
Pinnacle Foods, Inc.
PF
|
+$14.8M |
| 4 |
MON
Monsanto Co
MON
|
+$14.6M |
| 5 |
COL
Rockwell Collins
COL
|
+$10.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cognizant
CTSH
|
+$51.6M |
| 2 |
KSU
Kansas City Southern
KSU
|
+$31.5M |
| 3 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
+$4.46M |
| 4 |
Pacira BioSciences
PCRX
|
+$3.08M |
| 5 |
OTIC
Otonomy, Inc.
OTIC
|
+$2.83M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 79.82% |
| 2 | Technology | 4.67% |
| 3 | Consumer Staples | 4.04% |
| 4 | Financials | 3.49% |
| 5 | Industrials | 2.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
PF
1
PUT
DELISTED
Pinnacle Foods, Inc.
PF
| $116M | 10.42% |
2,137,300
+1,120,800
| +110% | +$64.6M |
2017 Q4
1 quarter
|
|
|
LCI
2
PUT
DELISTED
Lannett Company, Inc.
LCI
| $44.1M | 3.98% |
688,850
+240,025
| +53% | +$18.5M |
2017 Q3
2 quarters
|
|
|
PF
3
DELISTED
Pinnacle Foods, Inc.
PF
| $40.5M | 3.65% |
749,057
+257,240
| +52% | +$14.8M |
2017 Q4
1 quarter
|
|
|
IMMU
4
PUT
DELISTED
Immunomedics Inc
IMMU
| $34.3M | 3.1% |
2,349,300
+881,000
| +60% | +$14.4M |
2017 Q2
3 quarters
|
|
|
IMMU
5
CALL
DELISTED
Immunomedics Inc
IMMU
| $31.5M | 2.84% |
2,158,400
+395,100
| +22% | +$6.46M |
2017 Q1
4 quarters
|
|
|
SCG
6
PUT
DELISTED
Scana
SCG
| $21.7M | 1.96% |
+578,500
| New | +$23.2M |
2018 Q1
0 quarters
|
|
7
CALL
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $21.5M | 1.94% |
1,021,000
+598,300
| +142% | +$11.7M |
2017 Q4
1 quarter
|
|
8
CALL
Neighborhood Intelligence Inc
NXH
$188M
| $20.4M | 1.84% |
1,833,852
+518,158
| +39% | +$24.3M |
2017 Q3
2 quarters
|
|
9
CALL
Merck
MRK
$359B
| $19.1M | 1.72% |
+366,800
| New | +$19.8M |
2018 Q1
0 quarters
|
|
|
10
NXP Semiconductors
NXPI
$58.3B
| $19.1M | 1.72% |
+162,903
| New | +$19.7M |
2018 Q1
0 quarters
|
|
11
PUT
Trip.com Group
TCOM
$25.1B
| $16.3M | 1.47% |
+350,000
| New | +$16.4M |
2018 Q1
0 quarters
|
|
|
LCI
12
DELISTED
Lannett Company, Inc.
LCI
| $14.8M | 1.34% |
+231,290
| New | +$17.8M |
2018 Q1
0 quarters
|
|
13
CALL
DELISTED
Esperion Therapeutics
ESPR
| $14.7M | 1.33% |
+203,400
| New | +$14.9M |
2018 Q1
0 quarters
|
|
|
MON
14
DELISTED
Monsanto Co
MON
| $14.6M | 1.32% |
125,000
+121,500
| +3,471% | +$14.6M |
2017 Q4
1 quarter
|
|
|
EGOV
15
PUT
DELISTED
NIC Inc
EGOV
| $11.1M | 1% |
829,600
+407,900
| +97% | +$6.05M |
2017 Q4
1 quarter
|
|
|
COL
16
DELISTED
Rockwell Collins
COL
| $10.7M | 0.97% |
79,479
+75,979
| +2,171% | +$10.4M |
2017 Q4
1 quarter
|
|
|
VR
17
DELISTED
Validus Hold Ltd
VR
| $10.7M | 0.96% |
+158,361
| New | +$9.97M |
2018 Q1
0 quarters
|
|
|
18
PUT
DELISTED
Esperion Therapeutics
ESPR
| $10.6M | 0.96% |
+146,900
| New | +$10.8M |
2018 Q1
0 quarters
|
|
|
AET
19
DELISTED
Aetna Inc
AET
| $10.1M | 0.91% |
60,000
+56,500
| +1,614% | +$10.2M |
2017 Q4
1 quarter
|
|
|
XL
20
DELISTED
XL Group Ltd.
XL
| $9.95M | 0.9% |
+180,000
| New | +$7.9M |
2018 Q1
0 quarters
|
|
|
21
PUT
NXP Semiconductors
NXPI
$58.3B
| $9.32M | 0.84% |
79,700
-87,300
| -52% | -$10.5M |
2017 Q2
3 quarters
|
|
|
EGOV
22
DELISTED
NIC Inc
EGOV
| $9.28M | 0.84% |
+697,556
| New | +$10.3M |
2018 Q1
0 quarters
|
|
23
CALL
Heron Therapeutics
HRTX
$70.7M
| $9.27M | 0.84% |
+335,500
| New | +$7.61M |
2018 Q1
0 quarters
|
|
|
DST
24
DELISTED
DST Systems Inc.
DST
| $8.24M | 0.74% |
+98,500
| New | +$8.02M |
2018 Q1
0 quarters
|
|
|
KS
25
DELISTED
KapStone Paper and Pack Corp.
KS
| $7.2M | 0.65% |
+209,720
| New | +$6.69M |
2018 Q1
0 quarters
|
|
Similar funds
FFM
AWA
SC
HCM
NB
WFA
RIM
AU
DLD Asset Management's Q1 2018 Portfolio in Review
As of Q1 2018, DLD Asset Management held 149 positions worth $1.11B, down 19% from $1.38B the previous quarter. Its ten largest holdings account for 48% of the portfolio.
DLD Asset Management withdrew a net $325M in Q1 2018, closing 45 positions and reducing 6 holdings. Its most notable exit was Cognizant, an estimated $51.6M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 80% of assets, down from 90% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, DLD Asset Management opened a new position in NXP Semiconductors worth $19.1M.
- DLD Asset Management's largest Q1 2018 buy was NXP Semiconductors: 162,903 shares worth $19.1M.
- DLD Asset Management added most to Pinnacle Foods, Inc. in Q1 2018, an estimated $14.8M increase.
- DLD Asset Management's biggest Q1 2018 reduction was Sinovac Biotech, Ltd, cutting an estimated $26.4K.
- DLD Asset Management fully exited Cognizant in Q1 2018, selling an estimated $51.6M.
- DLD Asset Management's ten largest holdings make up 48% of its $1.11B portfolio in Q1 2018.
- DLD Asset Management opened 61 new positions and closed 45 in Q1 2018.
- DLD Asset Management's portfolio value fell 19% quarter-over-quarter to $1.11B.
Based on DLD Asset Management's 13F filing for Q1 2018, filed 14 May 2018.